ALCON REPORTS STRONG FIRST-QUARTER 2024 RESULTS DRIVEN BY …
May 13, 2024 Alcon reported diluted earnings per share of $0.50 and core diluted earnings per share 2 of $0.78 in the first quarter of 2024. "Our first-quarter results reflect the outstanding … From alcon.com
May 28, 2025 “Today marks a tremendous milestone for Alcon as TRYPTYR becomes our first prescription pharmaceutical treatment to be approved by the FDA since becoming an … From investor.alcon.com
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. From investor.alcon.com
A career at Alcon means being part of a team dedicated to delivering sight-saving and sight-enhancing solutions throughout the world. We aspire to lead the world in innovating life … From alcon.com
El trabajo que realizamos en Alcon es vital para ayudar a la salud visual de las personas, y cómo actuamos en el entorno laboral, en el mercado y en la sociedad determina nuestro éxito como … From co.alcon.com
Alcon provides Eye Care Professionals comprehensive eye health education, hands-on experiential learning opportunities and cutting-edge virtual reality technology for immersive … From alcon.com
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary … From alcon.com
Nos comprometemos a mostrar integridad en todo lo que hacemos. El trabajo que realizamos en Alcon es vital para ayudar a las personas a ver mejor; cómo manejamos el negocio en el … From mx.alcon.com
Our mission is to provide innovative vision products that enhance quality of life by helping people see better. From vision research to eye health, learn more at Alcon.com. From alcon.com
Are you curently on diet or you just want to control your food's nutritions, ingredients? We will help you find recipes by cooking method, nutrition, ingredients...
